| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Lyons Gary A is a Director at NBIX, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 31 sales. Those positions are worth an estimated $3.9M at current prices.
Our model assigns Lyons Gary A a middling insider score of 54/100, based on 14 past trades. Over a 12-month horizon, 38.5% of those trades were profitable, with an average 12-month return of -4.9%.
Lyons Gary A's largest disclosed position is in TVTX as Director, worth about $3.9M. The recent filings there lean toward selling, a net 58,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 5,000 | $110.06 | $550,315.50 | -2.4% | +5.4% | +14.9% | |
| Oct 31, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $114.76 | $1,721,403.00 | -6.9% | -5.9% | -3.6% | |
| Oct 4, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $110.54 | $552,711.00 | -2.4% | +9.9% | +1.3% | |
| Apr 25, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $92.76 | $1,391,392.50 | -6.7% | +1.6% | +9.2% | |
| Oct 7, 2021 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $105.06 | $525,293.50 | -2.3% | -19.2% | +5.1% | |
| Jun 10, 2021 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $100.27 | $1,002,743.00 | -4.5% | -5.7% | -6.2% | |
| Jan 26, 2021 | NBIX Neurocrine Biosciences Inc | Director | Sell | 2,000 | $120.02 | $240,046.56 | -0.9% | - | - | |
| Nov 8, 2019 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $110.00 | $550,000.00 | -2.2% | - | - | |
| Nov 1, 2019 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $100.22 | $501,103.50 | -2.1% | - | - | |
| Jul 30, 2019 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $92.07 | $920,686.00 | -4.1% | - | - |